Events

All members have the option of attending our various HTC-centric events which include:

  • Spring and Fall Member Meetings: Bring HTC staff together to connect, share best practices, and learn about key issues impacting HTCs.
  • Continuing Education (CE) Meetings: Bring nurses, pharmacists, physical therapists, and social workers together for discipline-specific continuing education, peer learning, and networking in support of the bleeding disorders community.
  • New HTC Staff Meeting: Brings staff new to their HTC or transitioning into a more operational role together to build knowledge, make connections, and better understand 340B and HTC operations.
  • Medical Providers & Business Administrators (MPBA) Meeting: HTC leaders come together to connect, collaborate, and plan for the future.
  • Member Webinars: Educate our members on HTC operations and organizational management, payer relations, regulations and legal updates, advocacy, and manufacturer updates.


Relevant non-member meetings and events within the bleeding disorder community are also listed here.

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from Pfizer on Complications and challenges associated with hemophilia and a rebalancing approach with HYMPAVZI™ (marstacimab-hncq)

Date: Tuesday, May 6th, 2025 Time: 2:00pm - 3:00pm ET         WEBINAR TOPIC: Complications and challenges associated with hemophilia and a rebalancing approach with HYMPAVZI™ (marstacimab-hncq) OBJECTIVES: Educate attendees on complications and challenges associated with hemophilia, the novel mechanism of action of HYMPAVZI, the BASIS Ph3 clinical trial results and dosage and Read the full article...

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from Sanofi – Exploring data and expert perspectives on Qfitlia™ (fitusiran)

Date: Wednesday, May 7th, 2025 Time: 1:00pm - 2:00pm ET       WEBINAR TOPIC: Exploring data and expert perspectives on Qfitlia™ (fitusiran) OBJECTIVE: During this program, we will explore data and expert perspectives on Qfitlia™ (fitusiran), a newly approved prophylactic treatment for patients with hemophilia A and B, with or without inhibitors. SPEAKER: Vanessa Read the full article...

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from BioMarin – A Collaborative Journey – ROCTAVIAN Patient & Provider Perspectives

Date: Tuesday, May 13th, 2025 Time: 1:00pm - 2:00pm ET       WEBINAR TOPIC: A Collaborative Journey - ROCTAVIAN Patient & Provider Perspectives OBJECTIVE: Join us for an insightful webinar exploring the real-world experiences of patients and providers with ROCTAVIAN. Hear firsthand accounts of the treatment journey, from initial consultations and administration to outcomes Read the full article...